Glioblastoma is the most frequent and aggressive brain cancer. Via pioneering the integration of imaging and immunology, we not only advance basic glioblastoma science but we also open up novel avenues for research.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Nov 27, 2024 |
| Journal | Acta neuropathologica communications |
| Authors | Heugenhauser Johanna, Visus Carmen, Buchroithner Johanna, Marosi Christine, Rössler Karl |
| DOI | 10.1186/s40478-024-01888-8 |
| Source | PubMed |